On March 14, 2014, Coronado Biosciences, Inc. (NASDAQ:CNDO) issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2013. Coronado Biosciences Inc. (NASDAQ:CNDO) shares after opening at $2.07 moved to $2.07 on last trade day and at the end of the day closed at $1.87. Company price to sales ratio in past twelve months was calculated as – and price to cash ratio as 0.83. Coronado Biosciences Inc. (NASDAQ:CNDO) showed a negative weekly performance of -5.08%.
On April 3, 2014 BioTelemetry, Inc. (NASDAQ:BEAT) through its wholly-owned subsidiary CardioNet, LLC completed its previously announced acquisition of substantially all of the assets of the cardiac event monitoring business of Biomedical Systems Corporation pursuant to the terms and conditions of an Asset Purchase Agreement between CardioNet and the Seller. BioTelemetry, Inc. (NASDAQ:BEAT) shares fell -7.71% in last trading session and ended the day on $10.17. BEAT return on equity ratio is recorded as -14.10% and its return on assets is -10.70%. BioTelemetry, Inc. (NASDAQ:BEAT) yearly performance is 332.77%.
Uranerz Energy Corporation (NYSEMKT:URZ) on 14 march has released its financial results for the year ended December 31, 2013 as filed with the United States Securities and Exchange Commission (“SEC”) and in Canada with the Canadian securities administrators. Uranerz Energy Corp. (NYSEMKT:URZ) shares moved down -7.87% in last trading session and was closed at $1.64, while trading in range of $1.63 – $1.78. Uranerz Energy Corp. (NYSEMKT:URZ) year to date (YTD) performance is 28.13%.
Brightcove (NASDAQ:BCOV), a leading global provider of cloud services for video, on 3 April announced that it has added support in its Zencoder service for new encoding formats for the next generation of Web and mobile playback that address the diverse needs of broadcasters and other professional content providers. Brightcove Inc. (NASDAQ:BCOV) weekly performance is -5.74%. On last trading day company shares ended up $9.20. Brightcove Inc. (NASDAQ:BCOV) distance from 50-day simple moving average (SMA50) is -9.78%. Analysts mean target price for the company is $17.08.